Cellibre
Turns cells into specialized, sustainable factories for the manufacture of globally significant products at scale.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | $2.0m | Grant | |
| Total Funding | 000k | ||
Related Content
Cellibre operates in the biomanufacturing sector, focusing on the sustainable production of cannabinoid ingredients through advanced cellular engineering. The company serves pharmaceutical, wellness, and consumer goods industries by providing high-quality, cost-effective cannabinoid compounds. Cellibre leverages fermentation technology to move production from traditional agricultural methods to controlled environments, enhancing efficiency and reducing environmental impact. The business model revolves around licensing its proprietary technology and selling the produced cannabinoids to various clients. Revenue is generated through technology licensing fees and direct sales of cannabinoid products.
Keywords: biomanufacturing, cannabinoids, cellular engineering, fermentation, sustainability, pharmaceuticals, wellness, consumer goods, technology licensing, cost-effective.